The CAFF has elected its new Board of Directors and has approved adding two new members.

Jiří Hanzlík, Director of Sandoz ČR, has been re-elected Chairman of the Board of Directors of the Czech Association of Pharmaceutical Companies (CAFF) for the years 2024-2026. Martin Bolcek, CFO of Gedeon Richter CZ, became the new vice chairman of the CAFF's Board of Directors. As of January, CAFF will be expanded to include radiopharmaceutical manufacturers RadioMedic and Tillotts Pharma, whose portfolio includes drugs for idiopathic intestinal inflammation.